Transarterial chemoembolization: Clinical Trials

6 trials of Transarterial chemoembolization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 31Completed 1

Follow Transarterial chemoembolization: new trials by email Literature Review of Transarterial chemoembolization trials Research Report on Transarterial chemoembolization

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver
Bland Embolization, Transarterial chemoembolization, Drug Eluting Beads Embolization - Neuroendocrine Tumor, Malignant, Liver Metastases
Phase 2CompletedAbramson Cancer Center at Penn Medicine1622016-03-012025-01-06
HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B
Hepatic arterial infusion, Transarterial chemoembolization, Folfox Protocol - Hepatocellular Carcinoma
Phase 2CompletedSun Yat-sen University792015-10-012017-02-09
Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma
ADI-PEG 20, Transarterial chemoembolization - Unresectable Hepatocellular Carcinoma
Phase 2CompletedPolaris Group302014-10-152018-09-04
Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer
sunitinib malate, Placebo, transarterial chemoembolization - Liver Cancer
Phase 2 / Phase 3CompletedFederation Francophone de Cancerologie Digestive782010-07-012022-03-18
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
epirubicin and lipiodol - Hepatocellular Carcinoma
Phase 2CompletedEastern Hepatobiliary Surgery Hospital4502009-01-012016-04-01
Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
CT-guided brachytherapy, transarterial chemoembolization - Hepatocellular Carcinoma
Phase 2CompletedUniversity of Magdeburg772006-10-012015-12-03

Conditions studied

Carcinoma, Hepatocellular (4)  ·  Liver Neoplasms (2)  ·  Neuroendocrine Tumors (1)

Sponsors

Abramson Cancer Center at Penn Medicine (1)  ·  Eastern Hepatobiliary Surgery Hospital (1)  ·  Federation Francophone de Cancerologie Digestive (1)  ·  Polaris Group (1)  ·  Sun Yat-sen University (1)  ·  University of Magdeburg (1)

Countries

China (2)  ·  Argentina (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Jens Ricke, M.D. (1)  ·  Michael C Soulen, MD, FSIR (1)  ·  Ming Shi, MD (1)  ·  Mohamed Hebbar, MD (1)  ·  Pei-Jer Chen, MD, PhD (1)

Results publications

PMID 30016989, PMID 32576496

NIH funding

2005 (1)